Hinge Health reported record third quarter 2026 results, with revenue growing 52% year-over-year to $235.0 million and non-GAAP EPS reaching $0.71. The performance was driven by a record sales season and rapid adoption of the company's expanding multi-product platform, including its recently integrated gastrointestinal and migraine programs.
Key Highlights
- Total revenue of $235.0 million beat the analyst estimate of $224.78 million, while LTM calculated billings surged 54% to $960.3 million.
- Expansion into adjacent care categories showed significant traction, with the GI Care Program client base growing 40% since the Cylinder Health acquisition announcement.
- Management raised its full year 2026 revenue midpoint to $880 million and increased its non-GAAP operating margin guidance to 30%.
- The company demonstrated high capital efficiency, generating $112.7 million in free cash flow for the quarter, representing a 48% margin.